DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

1.06 -0.04 (-3.64%)

REAL-TIME: Last trade at

Extended Hours: $1.10 $0.04 (3.77%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

CYCC $1.06 -3.64%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.10
Previous Close $1.10
Daily Range $1.03 - $1.12
52-Week Range $0.51 - $4.14
Market Cap $24.4M
P/E Ratio -1.34
Dividend (Yield) $0.00 (0.0%)
Volume 1,359,498
Average Daily Volume 1,743,681
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description

A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/

News & Commentary

Cyclacel Announces New Stock Issue

The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.

Health Care Sector Update for 03/04/2015: CYCC,NVGN,NSPR

Morning Market Losers

Biotech Weekly: When To Dash For The Trash (And When Not To)

Billionaires Got Burned by These Six Struggling Stocks in 2014

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More

Cyclacel Now An Exercise In Futility

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results -

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

Morning Market Losers

US Stocks to Open Lower as Housing Starts Miss Expectations; Ruble Plunge Weighs on World Markets

See More CYCC News...

CYCC's Top Competitors

CYCC $1.06 (-3.64%)
Current stock: CYCC
AMGN $159.60 (0.26%)
Current stock: AMGN
GILD $103.42 (0.34%)
Current stock: GILD
BIIB $425.61 (2.77%)
Current stock: BIIB